Fine Aromatics And Herbal Extracts Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 18-07-2024
- Paid Up Capital ₹ 9.90 M
as on 18-07-2024
- Company Age 20 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 1.05 Cr
as on 18-07-2024
- Revenue 28.47%
(FY 2023)
- Profit 148.64%
(FY 2023)
- Ebitda 164.16%
(FY 2023)
- Net Worth 7.69%
(FY 2023)
- Total Assets 6.68%
(FY 2023)
About Fine Aromatics And Herbal Extracts
The Corporate was formerly known as Fine Aromatic And Medicinal Extracts Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 9.90 M.
The company has closed loans amounting to ₹1.05 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Amol Shah and Kajal Shah serve as directors at the Company.
- CIN/LLPIN
U01117MH2004PTC148792
- Company No.
148792
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Sep 2004
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Fine Aromatics And Herbal Extracts?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kajal Shah  | Director | 01-Apr-2017 | Current |
| Amol Shah | Director | 23-Sep-2004 | Current |
Financial Performance and Corporate Structure Insights of Fine Aromatics And Herbal Extracts.
Fine Aromatics And Herbal Extracts Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 28.47% increase. The company also saw a substantial improvement in profitability, with a 148.64% increase in profit. The company's net worth moved up by a moderate rise of 7.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Fine Aromatics And Herbal Extracts?
In 2023, Fine Aromatics And Herbal Extracts had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Fine Aroma Specialities Private LimitedActive 4 years 1 monthAmol Shah and Kajal Shah are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 24 May 2006 | ₹1.05 Cr | Satisfied |
How Many Employees Work at Fine Aromatics And Herbal Extracts?
Unlock and access historical data on people associated with Fine Aromatics And Herbal Extracts, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Fine Aromatics And Herbal Extracts, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fine Aromatics And Herbal Extracts's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
